INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

DCF Advisers, LLC's Holding History (CIK: 0001802493)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 3,500 Value ($000) $462 Avg Close — Range —
Q4 2024
Shares 99,757 Value ($000) $8,332 Avg Close — Range —
Q3 2024
Shares 100,507 Value ($000) $7,354 Avg Close — Range —
Q2 2024
Shares 100,507 Value ($000) $6,884 Avg Close — Range —
Q1 2024
Shares 96,857 Value ($000) $6,703 Avg Close — Range —
Q4 2023
Shares 96,857 Value ($000) $6,937 Avg Close — Range —
Q3 2023
Shares 107,157 Value ($000) $5,582 Avg Close — Range —
Q2 2023
Shares 107,157 Value ($000) $6,785 Avg Close — Range —
Q1 2023
Shares 118,600 Value ($000) $6,422 Avg Close — Range —
Q4 2022
Shares 156,250 Value ($000) $8,269 Avg Close — Range —
Q3 2022
Shares 165,999 Value ($000) $7,724 Avg Close — Range —
Q2 2022
Shares 206,588 Value ($000) $11,792 Avg Close — Range —
Q1 2022
Shares 238,500 Value ($000) $14,594 Avg Close — Range —
Q4 2021
Shares 359,000 Value ($000) $18,790 Avg Close — Range —
Q3 2021
Shares 379,000 Value ($000) $14,129 Avg Close — Range —
Q2 2021
Shares 375,000 Value ($000) $15,308 Avg Close — Range —
Q1 2021
Shares 424,500 Value ($000) $14,403 Avg Close — Range —
Q4 2020
Shares 424,500 Value ($000) $13,499 Avg Close — Range —
Q3 2020
Shares 427,000 Value ($000) $10,957 Avg Close — Range —
Q2 2020
Shares 425,500 Value ($000) $10,923 Avg Close — Range —
Q1 2020
Shares 432,500 Value ($000) $6,648 Avg Close — Range —
Q4 2019
Shares 468,073 Value ($000) $16,060 Avg Close — Range —